Supporting and Enhancing NICU Sensory Experiences (SENSE) (SENSE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03316547 |
Recruitment Status :
Completed
First Posted : October 20, 2017
Results First Posted : July 7, 2021
Last Update Posted : July 7, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Double (Care Provider, Outcomes Assessor); Primary Purpose: Treatment |
Condition |
Premature Birth of Newborn |
Intervention |
Other: SENSE Program |
Enrollment | 70 |
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | Control | Intervention |
---|---|---|
Arm/Group Description | The control group received standard hospital care. |
Parents in the sensory-based intervention group were educated to provide daily sensory-based interventions across the length of hospitalization as outlined in the manualized intervention (the SENSE Program). A sensory support team completed the doses of sensory exposures when parents were unable. SENSE Program: Specific amounts of auditory, tactile, vestibular, kinesthetic, and visual exposure conducted daily through hospitalization. This includes specifically timed and set amounts of reading/talking/singing, cycled lighting, skin-to-skin (kangaroo) care or gentle human touch, rocking, and therapeutic exercises [passive range of motion (PROM), gentle stretching]. The intervention plan is intended to be implemented by parents when available, and by surrogates when the parents are unable to be present in the hospital. Specific amounts and timing of interventions will be tailored to the current medical status and age of each infant. |
Period Title: Overall Study | ||
Started | 39 | 31 |
Completed | 21 | 18 |
Not Completed | 18 | 13 |
Reason Not Completed | ||
Death | 3 | 1 |
Lost to Follow-up | 6 | 6 |
Withdrawal by Subject | 3 | 2 |
Transfer to another hospital | 6 | 4 |
Arm/Group Title | Control | Intervention | Total | |
---|---|---|---|---|
Arm/Group Description | The control group received standard hospital care. |
Parents in the sensory-based intervention group were educated to provide daily sensory-based interventions across the length of hospitalization as outlined in the manualized intervention (the SENSE Program). A sensory support team completed the doses of sensory exposures when parents were unable. SENSE Program: Specific amounts of auditory, tactile, vestibular, kinesthetic, and visual exposure conducted daily through hospitalization. This includes specifically timed and set amounts of reading/talking/singing, cycled lighting, skin-to-skin (kangaroo) care or gentle human touch, rocking, and therapeutic exercises [passive range of motion (PROM), gentle stretching]. The intervention plan is intended to be implemented by parents when available, and by surrogates when the parents are unable to be present in the hospital. Specific amounts and timing of interventions will be tailored to the current medical status and age of each infant. |
Total of all reporting groups | |
Overall Number of Baseline Participants | 39 | 31 | 70 | |
Baseline Analysis Population Description |
[Not Specified]
|
|||
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 39 participants | 31 participants | 70 participants | |
<=18 years |
39 100.0%
|
31 100.0%
|
70 100.0%
|
|
Between 18 and 65 years |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
>=65 years |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Age, Continuous
Mean (Standard Deviation) Unit of measure: EGA at birth (weeks) |
||||
Number Analyzed | 39 participants | 31 participants | 70 participants | |
29.5 (2.5) | 29.7 (2.6) | 29.6 (2.5) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 39 participants | 31 participants | 70 participants | |
Female |
28 71.8%
|
19 61.3%
|
47 67.1%
|
|
Male |
11 28.2%
|
12 38.7%
|
23 32.9%
|
|
Race (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 39 participants | 31 participants | 70 participants | |
American Indian or Alaska Native |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Asian |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Native Hawaiian or Other Pacific Islander |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Black or African American |
10 25.6%
|
13 41.9%
|
23 32.9%
|
|
White |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
More than one race |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Unknown or Not Reported |
29 74.4%
|
18 58.1%
|
47 67.1%
|
|
Region of Enrollment
Measure Type: Count of Participants Unit of measure: Participants |
||||
United States | Number Analyzed | 39 participants | 31 participants | 70 participants |
39 100.0%
|
31 100.0%
|
70 100.0%
|
Name/Title: | Roberta Pineda |
Organization: | Washington University |
Phone: | 314-286-1304 |
EMail: | bobbi.pineda@chan.usc.edu |
Responsible Party: | Washington University School of Medicine |
ClinicalTrials.gov Identifier: | NCT03316547 |
Other Study ID Numbers: |
201601057 |
First Submitted: | August 15, 2017 |
First Posted: | October 20, 2017 |
Results First Submitted: | June 14, 2021 |
Results First Posted: | July 7, 2021 |
Last Update Posted: | July 7, 2021 |